Webinar: How to Avoid Delays in Your Early Phase Oncology Trial?
Many things can go array in your early phase oncology trials, from protocol development, taking care of a safety profile, getting the ethics committee / regulatory authority’s approval, managing vendors, and much more. They all cost precious time and increase the overall costs.
Despite the challenges, the number of oncology clinical trials increases year after year as more treatment options seek to reach the market. At the same time, these studies are becoming progressively more complex, bringing new challenges. So, often a simple question arises: how to avoid these delays in early phase oncology studies?
Planning your next oncology study?
Let’s talk how we can team up to overcome common challenges and ensure smooth processes.
What we will talk about?
How to avoid the most common delays in early phase oncology trials:
- Protocol development
- Safety profile
- Seeking approvals by the Ethics Committee/Regulatory Authority
- Safety Review Committees/Independent Monitoring Boards
- IP manufacturing
- Vendors and their management
Duration: 50 minutes.
Speakers:
- Vladimir Mukovozchik, Head of Project Management
- Artūras Pažėra, Senior Project Manager
Vladimir Mukovozchik
Head of Project Management
Other content that might interest you:
National differences for Pharmacovigilance in Europe
Join our webinar on “Navigating National Differences in Setting up a Pharmacovigilance System in Europe.” 🇪🇺 💊
Oncology trials in a shifting economical and geopolitical landscape
Webinar: Oncology trials in a shifting economical and geopolitical landscape The pharmaceutical and biotech fields are spinning around, seeking to...
How to set up a pharmacovigilance system?
Webinar: Setting up a pharmacovigilance system in Europe. Where to start? What to consider? Setting up a pharmacovigilance system is not as...
